| # | Drug | Count |
|---|---|---|
| 0 | CLOZAPINE | 9719 |
| 1 | DEXAMETHASONE | 7328 |
| 2 | DEXAMETHASONE 1.5 MG | 7324 |
| 3 | CYCLOPHOSPHAMIDE | 6903 |
| 4 | LENALIDOMIDE | 5832 |
| 5 | RITUXIMAB | 5392 |
| 6 | METHOTREXATE SODIUM | 4533 |
| 7 | CARBOPLATIN | 4474 |
| 8 | PALBOCICLIB | 4472 |
| 9 | PREDNISONE | 4249 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ERIBULIN MESYLATE | 459 | 0.1648 |
| 1 | RIBOCICLIB | 1616 | 0.1432 |
| 2 | DEXRAZOXANE HYDROCHLORIDE | 87 | 0.1424 |
| 3 | DEXRAZOXANE FOR INJECTION | 79 | 0.1413 |
| 4 | RHO (D) IMMUNE GLOBULIN | 41 | 0.1285 |
| 5 | CLOZAPINE | 9719 | 0.1208 |
| 6 | TRABECTEDIN | 178 | 0.1088 |
| 7 | VINORELBINE | 543 | 0.1059 |
| 8 | LURBINECTEDIN | 26 | 0.1040 |
| 9 | CEFTAROLINE FOSAMIL | 48 | 0.1013 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 14924 |
| 1 | Atypical Antipsychotic [EPC] | 11331 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 11029 |
| 3 | Platinum-based Drug [EPC] | 10306 |
| 4 | Alkylating Drug [EPC] | 10037 |
| 5 | Kinase Inhibitor [EPC] | 7595 |
| 6 | Thalidomide Analog [EPC] | 7549 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 6140 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 5569 |
| 9 | Microtubule Inhibitor [EPC] | 5472 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Topoisomerase Inhibitor [EPC] | 3602 | 0.0759 |
| 1 | Estrogen Receptor Antagonist [EPC] | 1337 | 0.0690 |
| 2 | Platinum-based Drug [EPC] | 10306 | 0.0628 |
| 3 | Alkylating Drug [EPC] | 10037 | 0.0605 |
| 4 | CD30-directed Immunoconjugate [EPC] | 336 | 0.0590 |
| 5 | CD33-directed Immunoconjugate [EPC] | 163 | 0.0563 |
| 6 | Microtubule Inhibitor [EPC] | 5472 | 0.0529 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 11029 | 0.0526 |
| 8 | Actinomycin [EPC] | 111 | 0.0523 |
| 9 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 676 | 0.0520 |